Fushimi Pharmaceutical Co., Ltd. No.171811
CDMBI (2-Chloro-1,3-dimethyl-1H-benzimidazol-3-ium chloride)
Creation Date: 6/JUN/2013
Revision Date: 17/MAR/2020

ＳＤＳ

Safety Date Sheet

1. Chemical Product and Company Identification
Product nameProduct code
Manufacturer/Supplier name
Address
Telephone number
Fax number
E-mail address
Emergency telephone number: CDMBI (2-Chloro-1,3-dimethyl-1H-benzimidazol-3-ium chloride): 171811: Fushimi Pharmaceutical Co., Ltd.
: 307 Minatomachi, Marugame, Kagawa 763-0042: 81-87-899-7743: 81-877-22-6280: info@fushimi.co.jp: 81-3-6361-9121

2. Hazards Identification
GHS classification
Physical hazards
Health hazards
Environmental hazards: Not available: Not available: Not available

Allocation of Label Elements
Hazard symbols
Signal word
Hazard statements
Precautionary statements
Other hazards: Not available: Not available: Not available: Not available: Not available

3. Composition/Information on Ingredients
Substance/mixture
Chemical name
Percent
CAS No.
Synonym
Chemical formula
Molecular weight: Pure compound: 2-Chloro-1,3-dimethyl-1H-benzimidazol-3-ium chloride: ＞95.0 % (NMR): 364774-78-7: CDMBI: C9H10Cl2N2: 217.11

4. First Aid Measures
After inhalation :If inhaled, remove to fresh air. If breathing becomes difficult, call a physician.
After skin contact :In case of contact, immediately wash skin with soap and copious amounts of water.
After eye contact :In case of contact with eyes, flush with copious amounts of water for at least 15 minutes. Assure
adequate flushing by separating the eyelids with fingers. Get medical attention.
After ingestion :If swallowed, wash out mouth with water provided person is conscious. Get medical attention.

5. Fire Fighting Measures
Extinguishing media :Suitable: Water spray. Carbon dioxide, dry chemical powder, or appropriate foam.
Prohibited extinguishing media :Date not available.
Specific hazards arising from the chemical :Emits toxic fumes under fire conditions.
1/4

Fushimi Pharmaceutical Co., Ltd. No.171811
CDMBI (2-Chloro-1,3-dimethyl-1H-benzimidazol-3-ium chloride)
Creation Date: 6/JUN/2013
Revision Date: 17/MAR/2020

Special protective equipment and precautions for fire-fighters :Wear self-contained breathing apparatus and protective clothing to prevent contact with skinand eyes.

6. Accidental Release Measures
Personal precautions :Exercise appropriate precautions to minimize direct contact with skin or eyes and prevent inhalation ofdust.
Environmental precautions :Do not let product enter the drains.
Methods for cleaning up :Sweep up, place in a bag and hold for waste disposal. Avoid raising dust. Ventilate area and wash spillsite after material pickup is complete.

7. Handling and Storage
Handling :Directions for safe handling: Avoid inhalation. Avoid contact with eyes, skin, and clothing. Avoid
prolonged or repeated exposure.
Storage :Store in a well-ventilated place. Keep container tightly closed.
Store locked up.

8. Exposure Controls /Personal Protection
Control Parameters :Date not available
Engineering controls :Safety shower and eye bath. Mechanical exhaust required.
General hygiene measures :Wash thoroughly after handling.
Personal protective equipment :Respiratory protection: Wear dust mask.
Hand protection: Protective gloves.
Eye protection: Chemical safety goggles.

9. Physical and Chemical Properties
AppearanceOdor
pH
Melting point/freezing point
Boiling point/range
Flash point
Evaporation Rate
Flammability or explosive limits
Vapor pressure
Vapor Density
Relative density
Solubility
Log Pow
Spontaneousignition temperature
Decomposition temperature
Viscosity: White powder: Faint characteristic odor
: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available

10. Stability and Reactivity
Reactivity
Chemical Stability
Possibility of Hazardous Reaction: Not available: Stable under normal conditions: Under fire conditions, harmful decomposition
2/4

Fushimi Pharmaceutical Co., Ltd. No.171811
CDMBI (2-Chloro-1,3-dimethyl-1H-benzimidazol-3-ium chloride)
Creation Date: 6/JUN/2013
Revision Date: 17/MAR/2020

Conditions to avoid

Incompatible materials
Hazardous decomposition products

products such as carbon monoxide and nitrogenoxide might be generated.
: Extremely high temperature.
All heat sources (hot, spark, and flame).
Wetness conditions.
: Strong oxidizing agents: Under fire conditions, harmful decomposition
products such as carbon monoxide, carbon
dioxide and nitrogen oxide might be generated.

11. Toxicological Information
Routes of Exposure
Symptoms
Toxicity
Acute toxicity
Skin irritation/corrosion
Serious eye damage/ irritation
Respiratory or skin sensitization
Reproductive cell mutagenicity
Carcinogenicity
Reproductive toxicity
Specific target organ toxicity(single exposure)Specific target organ toxicity(repeated exposure)
Aspiration hazard: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available

12. Ecological Information
Ecotoxicity:
Fish Toxicity
Earthworm Toxicity
Algal Growth Inhibition Test
Acute Immobilization Test
Persistance/degradability
Bioaccumulative potential
Mobility in soil
Results of PBT and vPvB Assessment
Other adverse effects: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available

13. Disposal Considerations
Observe all federal, state, and local environmental regulations. Do not dump this product into sewers, on
the ground or into any body of water. Contact a licensed professional waste disposal service to dispose ofthis material. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator
equipped with an afterburner and scrubber.

14. Transportation Information
UN Number
Shipping Name
Hazard ClassPacking Group
Hazard Labels
IMO
IATA
RID/ADR:::: No information available: No information available: Non-hazardous material: Non-hazardous material: Non-hazardous material

15. Regulatory Information
3/4

Fushimi Pharmaceutical Co., Ltd. No.171811
CDMBI (2-Chloro-1,3-dimethyl-1H-benzimidazol-3-ium chloride)
Creation Date: 6/JUN/2013
Revision Date: 17/MAR/2020

ENCS
ISHL::-Please refer to any other federal, state and local regulations.

16. Other Information
Warranty
The above information is believed to be correct but does not purport to be all inclusive and shall beused only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Fushimi Pharmaceutical Co., Ltd. shall not be held liable forany damage resulting from handling or from contact with the above product. See reverse side of invoiceor packing slip for additional terms and conditions of sale.
Disclaimer
For R&D use only. Not for drug, household or other uses.

4/4